When Jim Cramer took a look back at the past 12 months on the stock market, he officially declared it the year of the haves and the have-nots.
“The disparity within groups is extraordinary this year; the gulf between the winners deep and wide and pretty much unfathomable,” the “Mad Money” host said.
In fact, a few examples of the massive disparity between the groups of stocks ripped Cramer’s eyes right open.
In the category of the Internet, the three winners were Alphabet, Expedia and Facebook. Alphabet rejuvenated itself hiring Ruth Porat as chief financial officer, and Cramer thinks this was the right move. 2016 could be the year that Alphabet really monetizes YouTube.Even Facebook soared as it proved once again that it was a total money machine and a virtual monopolist of humans.
But there were some troubled losers in the same category, too. Yahoowas down a hideous 34 percent for the year because it is widely perceived as being behind its peers, even with its giant stake in Alibaba.
“You back out their Alibaba holdings, subtract Yahoo Japan, and you get, well, nothing. The stock is literally trading as if Yahoo itself is worthless,” Cramer said.
Read MoreCramer on 2015: Unfathomable disparity of stocks
When Dow Chemical and DuPont announced its megamerger two weeks ago, Cramer loved the deal. But as much as he loved that deal, he does not want investors to forget that the entire agriculture industry has been in a lot of pain lately.
It was not long ago that Wall Street used to love this group, thanks to the “feed the world” thesis. This is a theory that the global population was growing and transportation infrastructure was improving, thus there would be higher demand for food and everything else that is needed to keep livestock healthy and grow crops.
“The ag cohort was supposed to become a secular growth story where the stocks could rise slowly and steadily. Instead, the group has become toxic, as the feed the world thesis has meant starvation for your portfolio,” the “Mad Money” host said.
Cramer thinks there needs to be a sustained recovery in the underlying commodities, before agriculture stocks can make a comeback. So, while the world is still hungry, perhaps not hungry enough since there is an oversupply of nearly every crop under the sun.
Read MoreCramer: Agriculture feeds the world—not portfolios
One stock that roared this year was Constellation Brands, up 43 percent year-to-date. Cramer reiterated to investors that every December, money managers tend to find the best performing stocks and buy them aggressively through the end of the year — Constellation was one of those stocks.
Constellation Brands is the world’s leading purveyor of premium wines, and No. 3 brewer in the United States. It sells such recognizable brands as Corona, Modelo and Pacifico, along with Robert Mondavi and Clos du Bois wines and Svedka vodka.
Last month the company spent approximately $1 billion to buy Ballast Point Brewing, a fast grower in the craft beer space. Cramer spoke with Constellation’s CEO Rob Sands to learn more about where the company could be headed.
“We are the fastest growing major beer company for sure. We are providing basically — other than the entire craft industry — we are providing most of the growth in the entire beer market,” Sands said.
When Cramer reflected on recent activity in the stock market, it wasn’t just bad stocks that made him so nauseated. It was the bad stocks trading as if there is no price that makes them worth owning.
Cramer was shocked at how many stocks seem to be in a similar position to Encana, Genworth and United States Steel Corp (US Steel).
“Stocks that, if you didn’t know any better, can’t make it in their current forms and will have to reorganize in some fashion,” the “Mad Money” host said.
“The problem with these slippery slope single-digit names is that we cannot figure out if the stocks have fallen too much because of an overabundance of fear, of if the declines are saying ‘don’t you dare touch me, these are going to zero,’ ” Cramer said.
The scariest part of the market is that the danger is not just limited to these three companies. Cramer saw similar situations all over the place; in some ways, they are emblematic of the moment. The same issues can be found with bottom fishing the oil patch, and the entire steel group.
Read MoreCramer: Troubled companies that must reorganize
In such an uncertain environment, Cramer has gained an appreciation for companies that can produce consistent performance. One of those companies is Henry Schein, the world’s No. 1 distributor of products and services to both dentists and veterinarians, as well as a major supplier of vaccines.
And no matter what happens with the economy, people will still go to the dentist and take their animals to the vet. Henry Schein has also made a series of small acquisitions to strengthen its presence in these markets.
To learn more, Cramer spoke with Henry Schein’s chairman and CEO, Stanley Bergman.
“The opportunities in dental, in the medical, the physician practice area and the veterinary world are just phenomenal. There is just lots and lots of opportunity,” Bergman said.
In the Lightning Round, Cramer gave his take on a few caller-favorite stocks:
Pandora: “They got that favorable copyright decision and the stock spiked, so therefore that decision was money in the bank and I think it is OK to buy now.
GW Pharmaceuticals: “There is a lot of controversy now about whether this drug is going to be used in many different instances, and whether or not it has run its course. The speculative biotechs I don’t like. I like Celgene, I like Regeneron and I like Biogen for my charitable trust.”
[“source -cncb”]
